Mild Cognitive Impairment

Slides:



Advertisements
Similar presentations
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Advertisements

Department of Neurology, Mayo Clinic Arizona
Early Detection of Cognitive Disorders Robin J. Heinrichs, Ph.D., LP Neuropsychologist & Assistant Professor Director of Neuropsychology Laboratory.
Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.
Frontotemporal Dementia
Dementia and Aging Steven Huege, M.D Assistant Professor of Clinical Psychiatry Perelman School of Medicine at the University of Pennsylvania.
Mind Cancer: Alzheimer’s Disease and Related Dementias. William D. Rhoades, DO FACP Chair, Department of Medicine Advocate Lutheran General and Chicago.
Mary Ganguli’s Slides March 13 th Meeting. Mild Cognitive Impairment A View from the Trenches.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
MILD COGNITIVE IMPAIRMENT UNRESOLVED ISSUES
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Dementia with Lewy Bodies
Alexander I. Tröster, Ph.D. Department of Neurology
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Cognitive Disorders Madiha Anas Institute of Psychology Beaconhouse National University.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
NHPA’s Chapter 3. National Health Priority Areas A collaborative initiative endorsed by the Commonwealth and all state and territory governments, which.
Recognition of Dementia Syed Zaman Consultant Physician Geriatric Medicine Palmerston North Hospital.
Memory Impairments. Amnesia Loss of memory ability - usually due to lesion (damage) or surgical removal of various parts of the brain.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
بسم الله الرحمن الرحیم. Dementia Dementia is a condition characterised by a progressive decline of mental abilities accompanied by changes in personality.
Clear organic causes, where primary symptom is a significant deficit in cognitive ability changes in the person’s personality and behavior (due to the.
Crash characteristics of older pedestrian fatalities: Dementia pathology may be related to ‘at risk’ traffic situations Authors: Gorrie, C.A. Brown, J.
Mild Cognitive Impairment
Are There Sex Differences in sociodemographic background and cognitive Functions Among Patients With dementia,a comparative study among an Egyptian sample.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
1 A follow up study of mild cognitive impairment in Beijing ----finding from 10/66 study Zhaorui Liu, Chuanjun Zhuo, Yueqin Huang, Shuran Li, Institute.
Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
How to diagnose dementia? Dr. Sridhar Vaitheswaran 25 th October 2012.
HOW TO EXAMINE PATIENTS WITH DEMENTIA Serge Gauthier, MD, FRCPC McGill Centre for Studies in Aging Douglas Mental Health Research Institute.
MCI Conversion to Dementia: Clinic and Community-Based Studies
Understanding Mild Cognitive Impairment. Objectives Understand the concept of MCI Identify risk factors for progression to dementia Review clinical trial.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
GERIATRIC EDUCATION SERIES Presented in partnership by Funded in part by a grant from the EJC Foundation.
Alzheimer’s disease and other types of dementia Revised 1.
Alabama Brief Cognitive Screener (ABCs)
Clinical, cognitive and genetic predictors of conversion from amnestic mild cognitive impairment to Alzheimer’s disease in Chinese older adults (Chu LW,
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
NON PHARMACOLOGICAL THERAPY OF MENTAL IMAGERY AND RELAXATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT Poptsi Ε.,1,3, Κounti F.,1,3,Τsolaki, Μ. 1,2 1.
Used to be called Dementia Neurocognitive Disorders.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Mild Cognitive Impairment (MCI) Screening Tools for Primary Care Providers Jamila Hussain, PGY-3 Faculty Development Cook County-Loyola-Provident Family.
Cognitive Disorders Delirium, Dementia, Amnestic Disorders.
The role of Nutrition in Geriatric Mental Health Chih-Chiang Chiu, M.D., Ph.D. Department of Psychiatry, Taipei City Psychiatric Center.
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
Memory and Aging Educational Presentation Presented by Tessa Lundquist, M.S. University of Massachusetts Amherst.
Dementia F.Etessam. MD. Dementia A progressive impairment of cognitive functions occurring in clear consciousness.
Dementia Jaqueline Raetz, M.D.. Types of Dementia Alzheimer Dementia 70% Lewy Body Dementia about 22% Vascular Dementia 17% Frontotemporal Dementia Overall.
The Malfunctioning Mind: Degenerative Diseases of the Brain
The Malfunctioning Mind: Degenerative Diseases of the Brain
Dementia Jaqueline Raetz, M.D..
Embracing Their Reality: Making Assisted Living Dementia-Friendly
Mayo Clinic College of Medicine
Dementia Jaqueline Raetz, M.D..
by Edward J. Goetzl, Adam Boxer, Janice B. Schwartz, Erin L
Cognitive Disorders and Aging
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Early Dementia Distinguishing AD From MCI
Baseline Characteristics of the Subjects
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
Box plot showing the distribution of the TYM-MCI score for patients with SMC and aMCI/AD. aMCI/AD, amnestic mild cognitive impairment or Alzheimer’s disease;
Presentation transcript:

Mild Cognitive Impairment American Academy of Neurology John Hart, Jr., M.D.

Mild Cognitive Impairment Definition: clinically defined by an impairment in one or more cognitive domains for age, but do not meet criteria for dementia (Petersen et al., 1999) Significance: Mild Cognitive Impairment (MCI) is clinically identifiable precursor of dementia, particularly Alzheimer’s disease (AD)

Mild Cognitive Impairment Prevalence-population studies (Panza et al., 2005) ~3-5% for age 60 and older ~15% for age 75 and older Incidence (Bischkopf et al., 2002) Slightly higher for men than women Higher in older or with less education ~12-15 per 1000 person-years for 65 and older ~54 per 1000 person-years for age 75 and older

Mild Cognitive Impairment Established clinical consensus criteria (Winblad et al., 2004) Patient is not normal, but not demented (DSM-IV) Evidence of cognitive deterioration for age Objective measured decline over time in cognitive task performance, and/or Subjective report of decline by patient and/or informant and objective cognitive deficits Preserved activities of daily living and minimal to no impairment on complex instrumental functions

Mild Cognitive Impairment Rate of progression to dementia: Mayo Study: 220 followed for 3-6 years ~12% per year (~1-2% for population) Religious Study: 211 followed for ~4.5 years 30% deceased (1.7x higher than w/o MCI) 34% converted to AD (3.1x higher than w/o MCI) (Bennett et al., 2002) Can progress to AD, vascular dementia (Solfrizzi et al., 2004), Lewy Body Dementia (Bennett et al., 2005)

Mild Cognitive Impairment Neuropsychological impairments initially described for verbal and visual memory – amnestic MCI (Petersen et al., 1999) Deficits now described in single or multiple cognitive domains (e.g., language, visuospatial) yielding (Petersen, 2004; Winblad et al., 2004; Lopez et al., 2005) Multidomain amnestic (multiple cognitive domains including memory) Multidomain nonamnestic Single domain nonmemory

Pathology Possible etiologies are Degenerative, vascular, metabolic, traumatic, psychiatric, or combination Pathology reflects condition as progresses If deceased prior to conversion to dementia, pathology is intermediate between normal and AD pathology

Mild Cognitive Impairment No other specific code captures Code needed as significant number diagnosed and diagnosis has profound implications General dementia diagnoses (290.x) not accurate since MCI has cognitive deficits but not impaired daily functions Memory loss (780.93) not capture since MCI does not have to be memory impairment

Mild Cognitive Impairment Organic personality syndrome (310.1) is for a memory deficit occurring after organic damage and refers primarily to the personality change Transient global amnesia (437.7) not relevant since MCI not transient Alzheimer’s disease (331.0), Vascular dementia (290.4), Frontotemporal dementias (331.19), and Dementia with Lewy Bodies (331.82) not accurate since are dementias

Mild Cognitive Impairment Would recommend coding in 331.x series (331.8) Is not simply memory loss Is a significant clinical change in cognitive status Mild Cognitive Impairment (331.83)